VANCOUVER, British Columbia, September 8, 2023 -- Biocure Technology Inc. (“CURE” or the “Company”) (CSE:CURE) announces that Sang Mok Lee has resigned from CEO and the board of directors. The Company would like to thank Mr. Lee for his contributions to the Company and wish him all the best for the future.

The Company is also pleased to announce that Yee Sing (Simon) Cheng has been appointed as CEO and the board of directors. Simon Cheng has over 10 years of experience of innovation and success in the technology and finance sector. His focus is on program development, with an emphasis on capital finance, business agreement negotiations and corporate development. He previously held positions with professional investment firms providing advisory services to high net worth individuals and institutional investors.

ON BEHALF OF THE BOARD OF DIRECTORS

/S/ “KONSTANTIN LICHTENWALD”
CFO and Director

For further information, please contact:

Biocure Technology Inc. Telephone: 604-609-7146, or This email address is being protected from spambots. You need JavaScript enabled to view it.

PRESS RELEASE ON PDF

Certain statements in this news release, which are not historical in nature, constitute “forward looking statements” within the meaning of that phrase under applicable Canadian securities law. These statements include, but are not limited to, statements or information concerning the Company’s proposed activities under the Agreement and the expectations of the Company regarding funding payments due pursuant to the Agreement. These statements reflect management’s current assumptions and expectations and by their nature are subject to certain underlying assumptions, known and unknown risks and uncertainties and other factors which may cause actual results, performance or events to be materially different from those expressed or implied by such forward looking statements. Except as required pursuant to applicable securities laws, the Company will not update these forward- looking statements to reflect events or circumstances after the date hereof. More detailed information about potential factors that could affect financial results is included in the documents filed from time to time with the Canadian securities regulatory authorities by the Company. Readers are cautioned not to place undue reliance on forward looking statements.

Neither the Canadian Securities Exchange (the “CSE”) nor the Investment Industry Regulatory Organization of Canada) accepts responsibility for the adequacy or accuracy of this release.